Will be testing Covid-19 vaccines in the months ahead. 20 major ones In discussions with 12 Believes we could get 6-8 contracts Expected to be £8-10m each.
Seems upbeat about the Covid testing, despite reiterating a few times we are not a Covid company as such. Says they have been inundated with demand for the testing since going live last week.
so there's no way Acacia will have sold all these assets (ORPH plus the rest affected recently) at a loss, which begs the question why didn't Link just sell the assets themselves? It's only taken a few days for them to be clear
So looks like Link found a buyer for 25 million, questions are did they sell the remaining 2.29% (I'd assume so given the fall over the past few days) and who did the 25m go to?
First RNS suggests Link held (8.67%) ~51,459,496 Bought by Acacia (6.51%) 38,618,608 Acacia holdings on 9th June (2.29%) 13.618.608 (assumed. above minus 25m)
The strangest thing is the ORPH site has had Link at 6.51 for ages:
I agree that link is certainly the most likely, but that 35.5m vs 35m seems a big coincidence. If Link why didn't they put through all 38M instead of 35?
RE: The simple fact of the matter is. Cathal has talked about newsflow8 Jun 2020 17:00
Swaplebar, that I agree with. Its all well and good doing a massive PR, and it would/will work very well, but it needs the RNSs and figures to accompany it.
11p was over subscribed by institutional investors, any reason why this would fall as low as "7/8p soon" apart from you wanting that price and plucking it out of thin air?